Regarding the meta-analyses of pharmacogenomics-guided antidepressant treatment: A response to Milosavljevic et al.-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Regarding the meta-analyses of pharmacogenomics-guided antidepressant treatment: A response to Milosavljevic et al.

Published:2024-11 Issue: Volume:88 Page:51-52
ISSN:0924-977X
Container-title:European Neuropsychopharmacology
language:en
Short-container-title:European Neuropsychopharmacology

Author:

Bunka Mary^ORCID,Austin Jehannine,Edwards Louisa,Wong Gavin,Bryan Stirling

Funder

Genome British Columbia

Publisher

Elsevier BV

Reference9 articles.

1. Improved efficacy with targeted pharmacogenetic-guided treatment of patients with depression and anxiety: a randomized clinical trial demonstrating clinical utility;Bradley;J. Psychiatr. Res.,2018

2. Evaluating treatment outcomes in pharmacogenomic-guided care for major depression: a rapid review and meta-analysis;Bunka;Psychiatry Res.,2023

3. GRADEpro GDT: GRADEpro Guideline Development Tool [Computer software];Anon,2020

4. A pharmacogenomic-based antidepressant treatment for patients with major depressive disorder: results from an 8-week, randomized, single-blinded clinical trial;Han;Clin. Psychopharmacol. Neurosci.,2018

5. Corrigendum: a pharmacogenomic-based antidepressant treatment for patients with major depressive disorder: results from an 8-week, randomized, single-blinded clinical trial;Han;Clin. Psychopharmacol. Neurosci.,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP